FAQ

terazosin hydrochloride

Known as: Terazosin Hydrochloride Dihydrate, terazosin hcl, terazosin, monohydrochloride, dihydrate 
The hydrochloride salt form of terazosin, a quinazoline derivative with adrenergic antagonistic property. Terazosin hydrochloride selectively… (More)

Topic mentions per year

Topic mentions per year

1983-2017
01219832017

Related topics

Related topics

8 relations
Arterial Vasodilation [PE]Decreased Blood Pressure [PE]Drug AllergyHypertensive disease
(More)

Narrower (1)

Hytrin

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
terazosin hydrochloride
Hypertensive disease
Drug Allergy
Quinazolines
Prostatic Hyperplasia
Terazosin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Fluorescent quantification of terazosin hydrochloride content in human plasma and tablets using second-order calibration based on both parallel factor analysis and alternating penalty trilinear…
Two second-order calibration methods based on the parallel factor analysis (PARAFAC) and the alternating penalty trilinear… (More)
Is this relevant?
2008
2008
Acute generalized exanthematous pustulosis caused by terazosin hydrochloride.
Acute generalized exanthematous pustulosis (AGEP) is a rare cutaneous eruption mainly provoked by drugs. A case of AGEP in a 74… (More)
Is this relevant?
2007
2007
Effects of branded versus generic terazosin hydrochloride in adults with benign prostatic hyperplasia: a randomized, open-label, crossover study in Taiwan.
BACKGROUND Terazosin is an alpha1-selective adrenoceptor blocking agent that has been reported in many clinical trials to be an… (More)
Is this relevant?
2006
2006
Identification, preparation, and characterization of several polymorphs and solvates of terazosin hydrochloride.
The phenomenon of polymorphism is prevalent in pharmaceuticals, yet it is unusual to identify more than three or four forms for… (More)
Is this relevant?
2002
2002
Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
PURPOSE For treating benign prostatic hyperplasia (BPH) 5 or 10 mg. terazosin hydrochloride daily has been routinely used in… (More)
Is this relevant?
2000
2000
Transdermal drug delivery using electroporation. I. Factors influencing in vitro delivery of terazosin hydrochloride in hairless rats.
The use of electroporation pulses as a physical means of enhancing the permeability of skin to deliver drugs is in the early… (More)
Is this relevant?
2000
2000
Transdermal drug delivery using electroporation. II. Factors influencing skin reversibility in electroporative delivery of terazosin hydrochloride in hairless rats.
A previous study indicated that the parameters governing the performance of electroporative delivery to the skin, are voltage… (More)
Is this relevant?
1997
1997
Terazosin blockade of nicotine-induced skin flap necrosis in the rat.
OBJECTIVE To examine the ability of terazosin hydrochloride to block the decrease in skin flap survival induced by nicotine… (More)
Is this relevant?
1991
1991
A multicentre, hospital study of the efficacy and safety of terazosin and its effects on the plasma cholesterol levels of patients with untreated essential hypertension.
The safety, efficacy and the effect on the plasma total cholesterol of once-daily terazosin hydrochloride administered as… (More)
Is this relevant?
1988
1988
Concomitant administration of terazosin and atenolol for the treatment of essential hypertension.
The safety and efficacy of once-daily terazosin hydrochloride administered concomitantly with once-daily atenolol for the… (More)
Is this relevant?